Shutout! The Baseball Writers Association of America fails to elect anyone to the Hall of Fame

185 Comments

It’s possible that this year’s Hall of Fame ballot was the most stacked in the history of the institution.  It contained the all-time home run leader. It contained a seven-time Cy Young award winner who may have been the best pitcher in baseball history since the deadball era. It contained the best hitting catcher of all time. It contained a middle infielder who got to 3,000 hits while flashing superior defense and power. It sported a 609-home run hitter a 583-home run hitter, the second best leadoff hitter in the history of the game and at least five others who, had they been inducted, would not be close to the worst players to make the Hall of Fame.

And none of them got in. Not a one. For the first time since 1996, all candidates on the ballot failed to receive the requisite 75% required for induction.  The leading vote getter was Craig Biggio, who received 68% of the vote. Jack Morris received 67.7%, Jeff Bagwell received 59.6% of the vote, Mike Piazza 57.8% and Tim Raines at 52.2%. No other player received more than 50% of the vote. Roger Clemens received 37.6% of the vote and Barry Bonds received 36.2%. Each of those last two received totals far below even the most pessimistic predictions. The full results can be seen here.

The biggest takeaway from all of this: the Baseball Writers Association of America has, for the first time, unequivocally decided that the use of performance enhancing drugs is a disqualifier for induction to the Hall of Fame. It was suspected that this was the case given Mark McGwire and Rafael Palmeiro falling short in previous years, but there are some reasonable non-PED arguments against those fellows’ candidacies.  Not so with Bonds and Clemens. They were so good and so accomplished that, to paraphrase Bill James, you could cut them in half and have two hall of famers each. Maybe three, actually. Their exclusion is solely because a large portion of the electorate believes that one cannot take steroids and call Cooperstown home.

Which, while understandable, flies in the face of baseball history. There are almost certainly already steroids users in the Hall of Fame. Indeed, Hall of Fame voter and Washington Post columnist Thomas Boswell said on camera, in Ken Burns’ “Tenth Inning” that he witnessed a current Hall of Famer taking steroids during his playing career. Maybe his fellow voters ignored him. Maybe, since that player’s induction, whoever he is, their attitudes have changed. Either way, there is certainly now a historical inconsistency baked into the Hall of Fame.  And in no event can anyone who applauds today’s voting results do so on the basis of the Hall of Fame maintaining its purity, for its purity is pure fantasy.

But just as the BBWAA has now clearly stated that drug users are not wanted in the Hall of Fame, it has apparently likewise erected a near-impossible hurdle for those not associated with PEDs to bound, regardless of their merits.

Craig Biggio had 3,000 hits. Tim Raines was one of the best players of the 1980s. Curt Schilling has three World Series rings, was dominant in the playoffs, and was one of the best pitchers in all of baseball for several years when being a pitcher in baseball was about as hard as it has ever been.  While I disagree that we should keep the PED players out, I at least understand the impulse. What’s the point of keeping out guys like Biggio, Raines and Schilling? What’s the point of the Hall of Fame if no one can get in in a year as talent-rich as this one?

But that’s where we are. Not one of the players on the ballot made it in. The induction ceremony in Cooperstown, New York this summer will honor three men — Hank O’Day, Jacob Ruppert, and Deacon White — who were elected by the Veterans Committee last month.  All three of those men have been dead since the 1930s, so I don’t presume it will be a joyful gathering of family and friends reminiscing about their storied pasts. It’ll be more like a memorial service.

Which is somewhat appropriate given that, with their votes, the current electorate is, in this writer’s view, hastening the Hall of Fame to its doom.

Phillies, Red Sox interested in Carlos Santana

Getty Images
6 Comments

The Phillies and Red Sox appear intent on pursuing free agent first baseman Carlos Santana, MLB Network’s Jon Morosi reports. Santana rejected a one-year, $17.4 million qualifying offer from the Indians on Thursday and is expected to draw widespread interest on the market this winter. The Mets, Mariners, Angels and Indians could make a play for the infielder, though no serious offers have been made this early in the offseason.

Santana, 31, is coming off of a seven-year track with the Indians. He batted .259/.363/.455 with 23 home runs and 3.0 fWAR last season, making 2017 the fourth-most valuable year of his career to date. Although he was primarily stationed at first base over the last year, he could step back into a hybrid first base/DH role with the Red Sox, who are hurting for infield depth with Hanley Ramirez still working his way back from shoulder surgery.

As for Santana’s other suitors, the Mariners are far less likely to pursue a deal after trading for Ryon Healy last Wednesday. Neither the Mets nor the Phillies have a DH spot to offer the veteran infielder, and the Phillies’ Rhys Hoskins appears to be blocking the way at first base. Then again, Santana may not find a more enticing offer outside of Cleveland, where Edwin Encarnacion might otherwise be the club’s best option at first base. During the GM meetings, Indians’ GM Mike Chernoff said he “love to have both [Santana and Jay Bruce] back” in 2018, but hasn’t backed up that love with any contract talks just yet.